Source: StreetInsider

Ampio: Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation

ENGLEWOOD, Colo., April 3, 2024 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE...

Read full article »
Ampio's Competitors | Ampio's News | Ampio's Financials
Stay up-to-date with the latest news on Ampio
Annual Revenue
$100K-5.0M
Employees
1-25
Michael A. Martino's photo - Chairman & CEO of Ampio

Chairman & CEO

Michael A. Martino

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Ampio